Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 0 Trial of Presurgical Vytorin in Prostate Cancer
NCT02534376Phase 1Completed
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Sep 2015
- Primary completion
- Feb 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Vytorin in prostate cancer (PCa), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Growth of Gleason grade 3 prostate cancer. Started Sep 2015; status: completed.
02
Drugs
Vytorin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02534376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02534376.